James M. D’Rozario

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Ivan Špıčka, Enrique M. Ocio, Heather Oakervee et al. · Annals of Hematology · 2019 · 57 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +12

Venetoclax Plus Rituximab Is Superior to Bendamustine Plus Rituximab in Patients with Relapsed/ Refractory Chronic Lymphocytic Leukemia - Results from Pre-Planned Interim Analysis of the Randomized Phase 3 Murano Study

John F. Seymour, Thomas J. Kipps, Barbara Eichhorst et al. · Blood · 2017 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +12

GASTROINTESTINAL HAEMORRHAGE

S P Kaushik, James M. D’Rozario, Guan C. Chong et al. · Journal of Gastroenterology and Hepatology · 1996 · 18 citations

Medicine, Pathology, Surgery +12